[{"id":"726d61ed-f804-458a-b056-93397dea9cac","acronym":"","url":"https://clinicaltrials.gov/study/NCT03677414","created_at":"2022-06-12T22:54:48.968Z","updated_at":"2024-07-02T16:37:06.744Z","phase":"","brief_title":"Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer","source_id_and_acronym":"NCT03677414","lead_sponsor":"Medical University of Graz","biomarkers":" EGFR • TP53 • PIK3CA • BRCA1 • PTEN • HRAS • RB1 • NRG1 • CTNNB1 • PIK3CB • SPOP • ZFHX3 • GRIN2A","pipe":" | ","alterations":" MLL3 mutation","tags":["EGFR • TP53 • PIK3CA • BRCA1 • PTEN • HRAS • RB1 • NRG1 • CTNNB1 • PIK3CB • SPOP • ZFHX3 • GRIN2A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MLL3 mutation"],"overall_status":"Unknown status","enrollment":" Enrollment 59","initiation":"Initiation: 09/10/2018","start_date":" 09/10/2018","primary_txt":" Primary completion: 01/31/2021","primary_completion_date":" 01/31/2021","study_txt":" Completion: 08/31/2021","study_completion_date":" 08/31/2021","last_update_posted":"2018-09-19"},{"id":"1a340b41-d902-4efc-9e35-58c5fa67008a","acronym":"ONCOBIL","url":"https://clinicaltrials.gov/study/NCT02893085","created_at":"2021-01-18T14:12:01.821Z","updated_at":"2024-07-02T16:37:26.868Z","phase":"","brief_title":"Pancreatico-biliary Tumor Mutation Profiling in Bile Samples","source_id_and_acronym":"NCT02893085 - ONCOBIL","lead_sponsor":"CHU de Reims","biomarkers":" BRAF","pipe":" | ","alterations":" MLL3 mutation","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MLL3 mutation"],"overall_status":"Completed","enrollment":" Enrollment 100","initiation":"Initiation: 09/01/2015","start_date":" 09/01/2015","primary_txt":" Primary completion: 10/01/2016","primary_completion_date":" 10/01/2016","study_txt":" Completion: 10/01/2016","study_completion_date":" 10/01/2016","last_update_posted":"2016-12-28"}]